Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and Standardization
Hematopoietic cell transplantation (HCT) is often a last resort, but potentially curative treatment option for children suffering from hematological malignancies and a variety of non-malignant disorders, such as bone marrow failure, inborn metabolic disease or immune deficiencies. Although efficacy...
Main Authors: | Jaap Jan Boelens, Kinga K. Hosszu, Stefan Nierkens |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2020.00454/full |
Similar Items
-
Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation
by: Linde Dekker, et al.
Published: (2020-07-01) -
Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Nataliya Prokopenko Buxbaum, et al.
Published: (2020-08-01) -
Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications
by: Giuseppe Lia, et al.
Published: (2020-03-01) -
Concise Review: Boosting T‐Cell Reconstitution Following Allogeneic Transplantation—Current Concepts and Future Perspectives
by: Laura Simons, et al.
Published: (2019-07-01) -
Immune reconstitution after allogeneic hematopoietic stem cell transplantation in children: a single institution study of 59 patients
by: Hyun O Kim, et al.
Published: (2013-01-01)